Hosted on MSN11mon
Cipla aims to grow respiratory leadership in the US; files Symbicort and another generic inhalerCipla announced that it filed two generic respiratory drug applications with the US FDA in the last quarter, including a generic version of Symbicort and one other undisclosed inhalation product.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback